Alzheimer Disease 13: Clinical Trials

1 trial for Alzheimer Disease 13, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Alzheimer Disease 13: new trials by email Literature Review of Alzheimer Disease 13 trials Research Report on Alzheimer Disease 13

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Spectris™ AD - Active, Spectris™ AD - Sham - Alzheimer Disease, Alzheimer Disease 1
Not applicableCompletedCognito Therapeutics, Inc.6732022-12-132026-09-09

Narrower conditions

Alzheimer Disease (1)  ·  Alzheimer Disease 10 (1)  ·  Alzheimer Disease 11 (1)  ·  Alzheimer Disease 12 (1)  ·  Alzheimer Disease 14 (1)  ·  Alzheimer Disease 15 (1)  ·  Alzheimer Disease 16 (1)  ·  Alzheimer Disease 5 (1)  ·  Alzheimer Disease 6 (1)  ·  Alzheimer Disease 7 (1)  ·  Alzheimer Disease 8 (1)  ·  Alzheimer Disease 9 (1)  ·  Alzheimer disease type 1 (1)  ·  Alzheimer disease type 2 (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)

Sponsors

Cognito Therapeutics, Inc. (1)

Countries

United States (1)

Top investigators

Robbert Zusterzeel, MD, PhD, MPH (1)